Literature DB >> 11674346

Applications of 5-Endo-trigonal Cyclization: Construction of Compounds Relevant to the Synthesis of Prostaglandins and Methyl epi-Jasmonate.

Mousumi Sannigrahi1, Darrin L. Mayhew, Derrick L. J. Clive.   

Abstract

Silane 15, easily constructed by simple methods, undergoes a cascade of radical reactions when treated with a stannane to afford the bicyclic 1,2-oxasiloles 16, with the major isomer having the ester group anti to the O-Si unit. This isomer was elaborated via 19 into 6, a deoxy derivative of the Corey lactone. In a related sequence, ketone 24 was converted into silane 35; this, too, underwent the radical cascade to afford the highly substituted 1,2-oxasiloles 36. Again the major isomer had the ester and O-Si units in an anti relationship. Elaboration of 36 (major isomer) gave the Corey lactone derivative 7. A key intermediate (32) in this second sequence was also prepared in optically pure form by starting with 2-deoxy-D-ribose. Compound 19 was converted into 8, a sequence that constitutes a formal synthesis of methyl (+/-)-epi-jasmonate. Two examples were found of selective silylation of a propargylic secondary hydroxyl in the presence of an ordinary secondary hydroxyl.

Entities:  

Year:  1999        PMID: 11674346     DOI: 10.1021/jo982225m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Enantioselective Syntheses of Yohimbine Alkaloids: Proving Grounds for New Catalytic Transformations.

Authors:  Eric R Miller; Karl A Scheidt
Journal:  Synthesis (Stuttg)       Date:  2021-11-02       Impact factor: 2.969

Review 2.  Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs.

Authors:  Constantin Tănase; Lucia Pintilie; Raluca Elena Tănase
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

3.  Pot and time economies in the total synthesis of Corey lactone.

Authors:  Nariyoshi Umekubo; Yurina Suga; Yujiro Hayashi
Journal:  Chem Sci       Date:  2019-12-23       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.